Elevance
Preço: 404.07Empresa e modelo de negócios
Elevance Health, Inc. operates in the healthcare sector, primarily providing managed care services. Its core products include health insurance plans and related services, targeting individuals, families, and employers. Major business segments encompass Commercial and Government segments, with significant revenue derived from premiums and service fees. The company focuses on improving health outcomes while managing costs through innovative healthcare solutions.
Perfil de investimento
Elevance's stock presents a profile that may appeal to balanced investors, given its combination of growth potential and dividend yield. The company's consistent revenue growth and moderate volatility suggest a stable investment environment. The dividend yield of 2.2% adds an income component, making it suitable for those seeking both capital appreciation and regular income.
Métricas fundamentais (experimental)
- EPS (TTM) — lucro por ação dos últimos 12 meses, $
- 23.51 OK
- Receita QoQ — crescimento da receita trimestre contra trimestre
- 0.9% ≈
- Surpresa de EPS
- 14.1% melhor que o esperado
- Volatilidade 20d
- 2.1% estável
- Dividend yield
- 1.6% moderado última data ex-dividendo: 2026-06-10
Impacto da previsão
positivoAcompanhar no portfólio
Gráfico de preço
| Data | Antes | Depois | Motivo |
|---|---|---|---|
| 2026-05-08 14:59 | — | Comprar | Strong fundamentals, but mixed momentum signals. |
| 2026-05-03 02:36 | Comprar | Manter | Компания Elevance Health демонстрирует стабильный рост выручки и положительные результаты по EPS, что указывает на сильные финансовые показатели. Умеренный риск связан с колебаниями на рынке, но текущие тренды и дивиденд |
| 2026-04-25 02:44 | Manter | Comprar | Компания Elevance Health демонстрирует стабильный рост выручки и положительные показатели EPS, что свидетельствует о ее финансовой устойчивости. Учитывая дивидендную доходность и недавний рост акций, инвестиции в компани |
| Data | Analista | Action | Alvo | Preço na época |
|---|---|---|---|---|
| 2026-06-08 11:27 | Mizuho Securities | Preço-alvo elevado | 435 → 465 | 415.53 |
| 2026-06-04 11:50 | Morgan Stanley | Preço-alvo elevado | 352 → 404 | 391.27 |
| 2026-06-01 11:26 | Truist Financial | Preço-alvo elevado | 375 → 450 | 393.19 |
Nada ainda